Literature DB >> 25789591

Iron and Parkinson's disease.

Francesco Di Lorenzo1.   

Abstract

In this case presentation, a man with a diagnosis of Parkinson's disease was treated with Chelation Therapy against iron without iron serum level correlation. The patient, who suffered from motor and non-motor symptoms of the disease, showed an improved condition after the Therapy. This clinical test was evaluated with UPDRS III score. The rationale and the limits of the Therapy are discussed. This case suggests that iron-dependent oxidative stress could represent a promising therapy for this dramatic disease; the necessity to deeply study the iron metabolism in neuro-degeneration appears really significant.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25789591

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  4 in total

Review 1.  α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.

Authors:  Sushil K Singh; Aloke Dutta; Gyan Modi
Journal:  Future Med Chem       Date:  2017-06-20       Impact factor: 3.808

Review 2.  Iron and zinc exploitation during bacterial pathogenesis.

Authors:  Li Ma; Austen Terwilliger; Anthony W Maresso
Journal:  Metallomics       Date:  2015-10-26       Impact factor: 4.526

3.  Metal and Microelement Biomarkers of Neurodegeneration in Early Life Permethrin-Treated Rats.

Authors:  Cinzia Nasuti; Stefano Ferraro; Rita Giovannetti; Marco Piangerelli; Rosita Gabbianelli
Journal:  Toxics       Date:  2016-01-29

4.  Hair Microelement Profile as a Prognostic Tool in Parkinson's Disease.

Authors:  Ferraro Stefano; Nasuti Cinzia; Piangerelli Marco; Guidi Marco; Giovannetti Rita; Ferri Augusto; Gabbianelli Rosita
Journal:  Toxics       Date:  2016-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.